Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONQUER: VI-0521 (Qsymia) in Obesity with Comorbidities
NCT00553787Phase 3Completed
- Sponsor
- VIVUS
- Start
- Nov 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of phentermine, topiramate in obesity, sponsored by VIVUS. Started Nov 2007; status: completed.
02
Drugs
phenterminetopiramate
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00553787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553787.